Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders - Wikidata - wikimedia - TriplyDB

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

http://www.wikidata.org/entity/Q35009426

about

From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study.Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy The neurobiology of the Prader-Willi phenotype of fragile X syndrome Vasopressin Proves Es-sense-tial: Vasopressin and the Modulation of Sensory Processing in Mammals.Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.Long-term exposure to intranasal oxytocin in a mouse autism model.Preliminary evidence for the interaction of the oxytocin receptor gene (oxtr) and face processing in differentiating prenatal smoking patterns.Ontogenesis of oxytocin pathways in the mammalian brain: late maturation and psychosocial disorders Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.Variants in Adjacent Oxytocin/Vasopressin Gene Region and Associations with ASD Diagnosis and Other Autism Related Endophenotypes.Initial investigation of three selective and potent small molecule oxytocin receptor PET ligands in New World monkeys ASD and Genetic Associations with Receptors for Oxytocin and Vasopressin-AVPR1A, AVPR1B, and OXTR.Activity Induces Fmr1-Sensitive Synaptic Capture of Anterograde Circulating Neuropeptide Vesicles.The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder.Oxytocin in animal models of autism spectrum disorder.Social neuroscience: undoing the schism between neurology and psychiatry.Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.Biomarker discovery for disease status and symptom severity in children with autism.Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings.Expanding Regulation Theory With Oxytocin: A Psychoneurobiological Model for Infant Development.Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study.

P2860

Q26770469-C4468A1C-6744-43A0-A1F0-E2847CD59D0B Q26771762-B98A9D92-7F76-450F-87E8-9B9160306FDE Q27303760-CCA62007-9B1B-4CD8-A584-55E357DE2170 Q27336849-3052EC3C-802A-45A8-BF7C-45A50442389D Q28078294-F68C1B6C-2C1C-4231-9C6D-66EA03A137EF Q30418389-BF470FFE-1D87-4402-8D5B-35FDF36A4431 Q34486374-01C10F5C-1D82-4E5A-B2B6-7A39D89C9287 Q34657990-3E473940-F130-4A07-A212-DC0D3BF3C0B5 Q34713836-947B0F91-9B74-4308-817E-ABAFD89690AC Q35123962-3B5985A5-D8A7-4D44-B6E9-2A2DA52649B2 Q35838291-4AF2F4B4-9C76-4DD1-AC4D-738FE31C08E3 Q36892246-29837A85-804B-4955-8FBD-92E49821B065 Q37055457-31314D2B-D667-46B5-B530-0DDBDE5E7B4C Q37427861-1E80DB38-D475-4A81-984D-4F03E86189CB Q37445047-8292F460-F57A-4B29-9099-3A7D7073445D Q38678068-BDCB15A1-CD3C-4300-AC7D-F075CFBB89DB Q38948413-7A58AD91-B54B-42E4-ADAA-8571C63CFFCE Q38972918-710D77F5-ED2E-454E-A3D0-DC8109FB2FCF Q41256682-D3D50EEA-BF4B-41DA-B014-3AA5378A839C Q47563967-766933BD-E7F6-4F25-A685-AD4C20AF7D97 Q52665859-615039AD-7358-48C2-9BED-6996F0C3FB34 Q52681491-8E6C6E6E-6A8A-479A-84CE-9090813D6127 Q52692298-1C1FD698-8F17-45AD-8B4E-19BD6E4F7965

P2860

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

http://www.wikidata.org/entity/Q35009426

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@ast

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@en

type

label

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@ast

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@en

prefLabel

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@ast

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@en

P1433

Q35009426-17616233-D151-4A2E-A011-1DCA1B893214

P1476

Q35009426-FC54F7F0-4BA0-47B4-8708-ADE3F9C6ED04

P2093

Q35009426-3B04F942-3C5C-45D4-9267-05BD2E6F814C

Q35009426-BC559ABE-D815-4A58-BD38-417E7386E554

Q35009426-D206C062-25A1-461B-AE91-F292ED338E81

Q35009426-E48A433E-BDAE-4A37-9DA8-B0E06A9B489A

P2860

Q35009426-006F5BB8-EF73-4105-A7B6-0BC5D8F1FC45

Q35009426-01327FB2-A8F8-4C35-840B-85D872530BD9

Q35009426-0157808D-350F-4A04-B292-4891740B0BF3

Q35009426-0185E1C3-A875-4E7B-AF60-5654B4296EC7

Q35009426-03C4917C-8443-45C9-9221-0C83D6922026

Q35009426-066A2CC4-20C2-4DF2-8888-ACCF1B6668BA

Q35009426-07E014C4-1918-46A6-8EA3-6B3FFABEB914

Q35009426-0A281601-F735-4636-99C8-EFE98C3AC74F

Q35009426-0A76A377-3871-4BAF-B8A2-97E8BB6E68E7

Q35009426-0AEBC6B7-2B52-45B4-850F-839C298BE4C1

P304

Q35009426-F75B5B91-8D90-4A1C-8894-CAD32285491B

P31

Q35009426-37B14203-FF84-437B-819C-592B1D599CEF

P356

Q35009426-FF3C04F4-CD81-4E8A-B216-3E21EAE9856E

P407

Q35009426-601B8315-1CB3-470A-8301-1433FE29F058

P478

Q35009426-627F808F-FA3F-46CE-BC18-ABD0A03D7FBF

P50

Q35009426-980AB066-F803-4C19-8E0E-09E822B61557

Q35009426-F563F9BF-8E9B-4B9A-8F27-D806F4408E97

P577

Q35009426-23D95BB8-BB0A-4252-B8DC-118FBB6D0C41

P5875

Q35009426-0B5A3AC5-3115-40DF-9FBB-F51F465013EA

P698

Q35009426-24A24481-ABE7-46EA-9055-1752688EAA4B

P921

Q35009426-71bfddac-a04b-4e08-8f62-ebb1c3bdbe62

Q35009426-78591092-3466-40D1-82C5-6689A9409B78

Q35009426-B9174FEA-C0A8-417E-87F1-029149627CE8

P932

Q35009426-016A8B27-DB12-4314-982E-4C0196C814AA

P356

J.BRAINRES.2014.01.021

P1433

P1476

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

@en

P2093

A Sagar

http://www.w3.org/2001/XMLSchema#string

C S Carter

http://www.w3.org/2001/XMLSchema#string

T Levin-Decanini

http://www.w3.org/2001/XMLSchema#string

W Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice.

Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

Oxytocin Makes a Face in Memory Familiar

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

Altered synaptic plasticity in a mouse model of fragile X mental retardation

Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice

Autism risk factors: genes, environment, and gene-environment interactions

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Advances in the treatment of fragile X syndrome

Fragile x syndrome

P304

199-218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BRAINRES.2014.01.021

http://www.w3.org/2001/XMLSchema#string

P407

P478

1580

http://www.w3.org/2001/XMLSchema#string

P50

Sunday M Francis

P577

2014-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259917196

http://www.w3.org/2001/XMLSchema#string

P698

24462936

http://www.w3.org/2001/XMLSchema#string

P921

neurodevelopmental disorders

P932

4305432

http://www.w3.org/2001/XMLSchema#string